Literature DB >> 22927213

Lysosome-dependent pathways as a unifying theme in Parkinson's disease.

George K Tofaris1.   

Abstract

Although the pathogenesis of Parkinson's disease (PD) is considered multifactorial, evidence from genetics and cell biology has implicated specific molecular pathways. This article summarizes evidence that suggests that the level of intracellular alpha-synuclein is critical for the onset of neurodegeneration with Lewy bodies and dependent, to a large extent, on lysosomal degradation. The function of other key proteins that emerged from genetics is discussed: Pink1 and Parkin regulate the degradation of damaged mitochondria by the lysosome (mitophagy). Glucocerebrosidase and ATP13A2 are important components of this degradative organelle. VPS35 and LRRK2 may regulate trafficking within lysosome-dependent pathways, such as autophagy and endosomal vesicle recycling. Clinically, diffuse alpha-synucleinopathy or dementia seems to correlate with mutations which interfere with the broader function of lysosomal pathways, whereas a predominantly motor syndrome and nigrostriatal degeneration is associated with specific defects in mitophagy. Based on these studies, it is proposed that a protein network involved in trafficking to, or degradation by, lysosomes could be sufficient to explain the phenotypic spectrum within PD in a unifying biochemical pathway.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22927213     DOI: 10.1002/mds.25136

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  51 in total

1.  Silencing synuclein at the synapse with PLK2.

Authors:  Brendan D Looyenga; Patrik Brundin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-26       Impact factor: 11.205

2.  LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.

Authors:  Dan Hu; Jian-Yi Niu; Jing Xiong; Shu-Ke Nie; Fei Zeng; Zhao-Hui Zhang
Journal:  Curr Med Sci       Date:  2018-12-07

3.  Proteomic and functional analyses in disease models reveal CLN5 protein involvement in mitochondrial dysfunction.

Authors:  Stefano Doccini; Federica Morani; Claudia Nesti; Francesco Pezzini; Giulio Calza; Rabah Soliymani; Giovanni Signore; Silvia Rocchiccioli; Katja M Kanninen; Mikko T Huuskonen; Marc H Baumann; Alessandro Simonati; Maciej M Lalowski; Filippo M Santorelli
Journal:  Cell Death Discov       Date:  2020-03-30

4.  Parkinsonism and Other Movement Disorders Associated with Chediak-Higashi Syndrome: Case Report and Systematic Literature Review.

Authors:  Bettina Balint; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2015-01-14

Review 5.  Mechanism and Regulation of Autophagy and Its Role in Neuronal Diseases.

Authors:  Zhiping Hu; Binbin Yang; Xiaoye Mo; Han Xiao
Journal:  Mol Neurobiol       Date:  2014-10-15       Impact factor: 5.590

Review 6.  Lysosomal impairment in Parkinson's disease.

Authors:  Benjamin Dehay; Marta Martinez-Vicente; Guy A Caldwell; Kim A Caldwell; Zhenyue Yue; Mark R Cookson; Christine Klein; Miquel Vila; Erwan Bezard
Journal:  Mov Disord       Date:  2013-04-11       Impact factor: 10.338

7.  Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.

Authors:  Xiao-Su Gu; Fen Wang; Cai-Yi Zhang; Cheng-Jie Mao; Jing Yang; Ya-Ping Yang; Sha Liu; Li-Fang Hu; Chun-Feng Liu
Journal:  Neurochem Res       Date:  2016-07-22       Impact factor: 3.996

Review 8.  Defective autophagy in Parkinson's disease: lessons from genetics.

Authors:  H Zhang; C Duan; H Yang
Journal:  Mol Neurobiol       Date:  2014-07-04       Impact factor: 5.590

Review 9.  [Genetics of movement disorders].

Authors:  K Lohmann; K Brockmann
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 10.  Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.

Authors:  Olive Jung; Samarjit Patnaik; Juan Marugan; Ellen Sidransky; Wendy Westbroek
Journal:  Expert Rev Proteomics       Date:  2016-04-21       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.